US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 10.070
  • +1.610+19.03%
Trading Apr 29 14:14 ET
310.92MMarket Cap-3675P/E (TTM)

Acrivon Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Apr 29, 2024

Based on 9 analysts giving stock ratings to Acrivon Therapeutics in the past 3 months

Strong Buy

  • Buy

    88.89%

  • Hold

    11.11%

  • Sell

    0.00%

Price Target

Updated: Apr 29, 2024

The average Acrivon Therapeutics stock price target is 22.71 with a max estimate of 30.00 and a min estimate of 17.00

Review Acrivon Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Apr 29, 2024

Strong Buy

  • Buy

    88.89%

  • Hold

    11.11%

  • Sell

    0.00%

Price Target

Updated: Apr 29, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg